newsfilter
← Latest News
ACCESS Newswire·

Hemogenyx Pharmaceuticals PLC Announces Approval and Issuance of Antibody Patent

Approval and Issuance of Chinese Bi-specific Antibody Patent LONDON, UK / ACCESSWIRE / August 15, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to anno